Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 29,972 $ 17,564
Restricted cash 203 312
Accounts receivable, less allowance of $2,154 and $4,017 as of December 31, 2021 and 2020, respectively 4,238 3,059
Inventory 12,929 11,157
Prepaid expenses and other current assets 2,012 3,018
Total current assets 49,354 35,110
Property, plant, and equipment, net 1,067 782
Goodwill 2,926 2,926
Right of use asset 1,717 1,976
Other assets 220 231
Total assets 55,284 41,025
Current liabilities:    
Accounts payable 3,309 2,651
Accrued liabilities 8,276 6,667
Deferred revenue, current portion 2,259 1,905
Total current liabilities 13,844 11,223
Deferred revenue 329 374
Warranty accrual 521 384
Non current term loans, net of discount 13,603 16,186
Non current operating lease liability 1,449 1,774
Other liabilities 330 1,056
Total liabilities 30,076 30,997
Commitments and contingencies —Note 7
Stockholders' equity:    
Series F Preferred stock, par value $0.001 per share; 18 shares authorized, 0 and 1 shares issued and outstanding as of December 31, 2021 and 2020, respectively 34 118
Common stock, par value $0.001 per share; 180,000 shares authorized, 153,721 and 97,709 shares issued and 153,676 and 97,663 shares outstanding as of December 31, 2021 and 2020, respectively 154 98
Additional paid-in capital 293,177 261,573
Accumulated other comprehensive loss (623) (385)
Accumulated deficit (267,534) (251,376)
Total stockholders' equity 25,208 10,028
Total liabilities, redeemable preferred stock and stockholders' equity $ 55,284 $ 41,025